Cowen Lowers Alphatec Price Target to $20, Cites Valuation While Keeping Buy Rating
TD Cowen reduced its price target on Alphatec Holdings (ATEC) from $27.00 to $20.00 while leaving its Buy rating intact. The cut - a 26% reduction from the prior target - comes amid questions about the premium investors should pay for a high-growth spine surgery company, even as Alphatec posts strong revenue gains and guidance that beats consensus.…